Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1376622 | Bioorganic & Medicinal Chemistry Letters | 2008 | 5 Pages |
Abstract
A potent IRAK-4 inhibitor was identified through routine project cross screening. The binding mode was inferred using a combination of in silico docking into an IRAK-4 homology model, surrogate crystal structure analysis and chemical analogue SAR.
Graphical abstractThe binding mode of a series of IRAK-4 inhibitors derived screening hit 1 was inferred using a combination of in silico docking into a homology model, surrogate crystal structure analysis and analogue SAR.Figure optionsDownload full-size imageDownload as PowerPoint slide
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
George M. Buckley, Thomas A. Ceska, Joanne L. Fraser, Lewis Gowers, Colin R. Groom, Alicia Perez Higueruelo, Kerry Jenkins, Stephen R. Mack, Trevor Morgan, David M. Parry, William R. Pitt, Oliver Rausch, Marianna D. Richard, Verity Sabin,